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Abstract
The hypothesis of a protective effect of fish oil supplementation in preventing some 
consequences of pregnancy such as gestational hypertension is put forward which has 
attracted increasing attention. The aim of the present study was to evaluate the effect of fish oil 
supplementation on outcomes of pregnancy. This study was a clinical trial performed on 339 
women with singleton pregnancy aged 18-35 and gestational age of 20 weeks who visited prenatal 
clinic at Kosar Hospital in Qazvin during 2015-2016. Patients were randomly divided into two 
groups marked as intervention group which received soft gelatin capsules (each containing 1000 
mg fish oil including 120 mg DHA and 180 mg EPA) on a daily basis from the 20th week to the 
end of pregnancy, and the women in the control group with no fish oil intake. The outcomes of 
pregnancy including preeclampsia, eclampsia, preterm labor, gestational diabetes, weight, height, 
head circumference at birth and the gestational age at delivery were evaluated in both groups. 
Data were analyzed using statistical tests including Mann-Whitney U test and t-test. There was 
significant difference in gestational age between the two study groups (P < 0.05). There was no 
significant difference in the percentage of preterm birth, preeclampsia, eclampsia, IUGR, and 
GDM between the two groups (P > 0.05). The results of this study showed that consumption of 
fish oil supplements from 20th week of gestation by 18-35 year-old pregnant women increased 
pregnancy age but failed to decrease the percentage of preterm birth, preeclampsia, eclampsia, 
IUGR, and GDM. 
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Introduction
The nutritional status of mother before 
and during pregnancy is a determination 
factor associated with morbidity  before and 
during childbirth, weight at birth, and other 
parameters related to appropriate feeding (1). 
Nutritional recommendations for mothers 
emphasize over the consumption of essential 
proteins, vitamins, and minerals nevertheless, 
in recent years the inclusion of long-chain 
unsaturated omega-3 fatty acids in the diet are 
also strongly suggested (2, 3). These essential 
fatty acids should be received through 
foods or food supplements as the human 
body can not synthesize such nutrients (4). 
Biologically, docosahexaenoic acid (DHA) 
and eicosapentaenoic acid (EPA) are the 
most active long-chain unsaturated omega-3 
fatty acids abundantly found in fish oil (5-7). 
Consumption of DHA and its concentration 
in mother’s blood flow is an important 
